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Isolated congenital factor VII (FVII) (proconvertin) deficiency is a rare autosomal recessive bleeding disorder. Bleeding manifestations and clinical findings vary widely. 
There may be asymptomatic or can develop to life-threatening 
bleeding [1]. Although the highest incidence of intracranial 
hemorrhage is observed in factor (F)XIII deficiency (∼30%), 
intracranial hemorrhage is less common in afibrinogenemia, 
FVIII, FIX, FVII, and FX deficiencies and is rare in severe 
FV and FII deficiencies, Type 3 von Willebrand disease and 
inherited platelet function disorders [2]. Treatment of congenital 
FVII deficiency consists of replacement therapy with fresh 
frozen plasma (FFP), prothrombin complex concentrates (PCCs) 
or plasma-derived FVII concentrates, and/or recombinant factor 
VIIa (rFVIIa) [3].
CASE REPORT
An 11-year boy was admitted to the department of neurosurgery 
with severe headache and vomiting for 2 days. It was not associated 
with convulsions, altered sensorium, or fever. The patient gave 
history of trauma to head 3 years back. He had vomiting and 
mild headache at that time. Computed tomography (CT) brain 
had revealed subdural hemorrhage in left temporoparietal 
region which was treated conservatively and was not further 
investigated for bleeding disorders. There was a history of single 
blood transfusion 4 years back when patient had a complaint of 
bleeding from rectum. There was no history of bleeding from 
any other site. The child was born of a non-consanguineous 
marriage after an uneventful pregnancy and delivery. He had one 
normal younger sibling. There was no significant family history 
suggestive of any bleeding disorder.
Physical examination revealed a pulse rate of 110 beats/min, 
respiratory rate 24/min, blood pressure of 100/70 mmHg, and 
body temperature was 37.3°C. He had mild pallor, but there 
were no icterus, petechiae, or ecchymosis. Ear, nose, and throat 
examination was within normal limits. Systemic examination did 
not reveal hepatosplenomegaly or lymphadenopathy. There were 
no clinical signs of hepatic dysfunction and neurological status 
of the child was normal. CT brain demonstrated a large right 
frontoparietal subdural hemorrhage 13 mm thick with midline 
shift of 10 mm toward left (Fig. 1).
The child received FFP preoperatively and underwent 
emergency evacuation of subdural hemorrhage due to worsening 
of neurological status. Postoperatively, he received eight units of 
FFP and Vitamin K. His post-operative period was uneventful and 
he was transferred later to the department of pediatrics for further 
management.
Laboratory findings were as follows: Hemoglobin 
9.8 g/dl; white blood cell count of 9100/mm3, and platelet count of 
313,000/mm3. Screening tests for hemostasis showed a bleeding 
time of 5 min (Ivy’s technique, normal 2–7 min) and a clotting 
time of 12 min (Lee and White, normal 4–9 min). Liver function 
tests were within normal limits. Coagulation profile showed 
that prothrombin time (PT) was prolonged 38 s (control 12 s), 
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partial thromboplastin time (PTT) with Kaolin was normal – 28 s 
(control 24 s) with INR of 4.28. Thrombin time was done which 
was normal - 7 s (control 8 s).
Serum fibrinogen level was within normal limits. Mixing 
studies were done in our patient. A 1:1 mixture of normal 
control plasma mixed with the patient’s plasma showed 
complete correction of PT. We did not screen for the presence 
of specific inhibitors as mixing studies showed normalization 
of PT. Since PT was repeatedly prolonged even after FFP 
and Vitamin K supplementation in the post-operative period, 
isolated FVII deficiency was suspected. Later on FVII assay 
was done, which showed the functional activity of 4.2% of 
normal (70.00–120.00). Coagulation profiles of both parents 
were within normal limits and thus the diagnosis of FVII 
deficiency was established. The child was asymptomatic on 
further 1 year follow-up. He did not require prophylactic FVII 
infusion during this period.
DISCUSSION
Congenital FVII deficiency is a rare autosomal recessive 
bleeding disorder that has a prevalence of 1 in 500,000 [4]. FVII 
deficiency was first described by Alexander et al. [5]. Cases of 
FVII deficiency were reported in India by Jagruti et al. [6] and 
Krishnan et al. [7]. Narang et al. reported combined FVII and 
X deficiency [8]. The clinical presentation of FVII deficiency 
is heterogeneous, and the bleeding severity is not directly 
related to the FVII levels [9]. Type 1 deficiency occurs due to 
decreased biosynthesis or accelerated clearance and Type 2 
abnormalities occur due to a dysfunctional molecule. Mostly, 
missense mutations have been identified in the FVII gene located 
on chromosome 13 which is mostly associated with missense 
mutations [10].
Acquired FVII deficiency may arise due to Vitamin K 
deficiency, Vitamin K antagonist therapy, or liver disease. 
In these conditions, reduced FVII levels are associated 
with reduced levels of other Vitamin K-dependent 
factors. Acquired FVII deficiency is more common than 
inherited deficiency [11,12]. There is a poor correlation 
between FVII coagulation activity and bleeding tendency [13]. 
Prolonged PT with a normal PTT should be suspected of FVII 
deficiency. The prolonged PT is corrected by normal serum 
as it is rich in FVII [14]. Definitive diagnosis can be made by 
specific assay of FVII activity.
rFVIIa is the most widely accepted replacement therapy in 
acute bleeding at 15–30 mg/kg of body weight. Thrombosis 
related to rFVIIa treatment is very rare and no risk of virus 
transmission, and rarely leads to the development of inhibitory 
antibodies. However, it has short half-life and is expensive. 
FFP is an effective, cheap, and easily available option but can 
cause fluid overload. It is acceptable for newborns (e.g., a 
minimally invasive diagnostic procedure or a minor cutaneous 
surgery). PCC and activated PCC were the possible options but 
are associated with post-treatment thrombosis. FFP, PCCs, and 
FVII concentrates are associated with the risk of transmission of 
pathogens [15]. Antifibrinolytic tranexamic acid could be used 
in minor bleeding symptoms such as mild menorrhagia alone 
or in combination with replacement therapy [15]. Prophylaxis 
programs should be established to prevent central nervous system 
and gastrointestinal bleeding episodes and/or their recurrences 
in infants with FVIIc levels <1%, and in young children with 
recurrent hemarthroses [16].
CONCLUSION
Isolated congenital FVII deficiency is a rare bleeding disorder 
suspected in a healthy bleeding child when platelets and activated 
PTT are normal and there is deranged PT. Clinical heterogeneity 
is the hallmark of this disorder; the severity ranges from lethal to 
mild, and there are asymptomatic forms.
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